 |
|
|
 |
|
Michael S. Paul, Ph.D.
|
|
| |
President and CEO |
| |
|
| |
Dr. Paul has been involved in numerous biomedical technology start-up and licensing initiatives. Dr. Paul was President and Chief Operating Officer at the non-profit LineaGen Research Corporation, responsible for all corporate development and operational activities. Prior to joining LineaGen Research Corporation, Dr. Paul worked for the start-up Huntsman Biotechnology Corporation as VP of Business Development, and for the publicly-traded biopharmaceutical company, NPS Pharmaceuticals, Inc. as Director of Strategic Development. |
| |
|
|
| |
Dr. Paul has successfully led multidisciplinary product development teams, formulated strategic development initiatives, and been responsible for the strategic management of corporate intellectual property. At NPS, he was involved in negotiations for several multi-million dollar licensing and corporate acquisition deals. Dr. Paul has also worked at the University of Utah Technology Transfer Office, where he has participated in marketing University inventions to the pharmaceutical and biotechnology industries. He is a licensed patent agent of the United States Patent and Trademark Office. Dr. Paul received his B.A. from Colby College and his Ph.D. from the University of Utah. |
|
| |
|
|
|
|
|
|
|
|
|